1. Academic Validation
  2. sRAGE Inhibits the Mucus Hypersecretion in a Mouse Model with Neutrophilic Asthma

sRAGE Inhibits the Mucus Hypersecretion in a Mouse Model with Neutrophilic Asthma

  • Immunol Invest. 2022 Jul;51(5):1243-1256. doi: 10.1080/08820139.2021.1928183.
Xiaobo Zhang 1 Jun Xie 1 Hongmei Sun 1 Qin Wei 1 Guangmin Nong 1
Affiliations

Affiliation

  • 1 Pediatric Department, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, P.R. China.
Abstract

Background: Neutrophilic asthma (NA) may result in irreversible airflow limitations. Soluble advanced glycosylation receptor (sRAGE) has been shown to be associated with neutrophilic airway inflammation. However, the association between sRAGE and mucus hypersecretion in NA remains unknown. This study aims to assess the function of sRAGE on mucus hypersecretion.

Methods: A NA mouse model was established and treated with adeno-associated virus 9 (AAV9)-sRAGE and inhibitors. Collagen deposition and goblet cell hyperplasia in the lungs were evaluated by periodic acid-Schiff (PAS) and Masson staining. sRAGE and Mucin levels in bronchoalveolar lavage fluid were measured by ELISA. Pathway molecule expression levels were determined by RT-qPCR and western blotting.

Results: The results showed that the NA mouse model exhibited airway mucus hypersecretion. Mice can be effectively transfected by AAV9-sRAGE via tail-vein injection and intranasal drip. AAV9-sRAGE increased the sRAGE levels but it inhibited the collagen deposition, the PAS score, as well as the expression of MUC5AC and MUC5B. Inhibitors of high-mobility group protein 1 (HMGB1), receptor for advanced glycation end product (RAGE) and phosphatidylinositol 3-kinase (PI3K) suppressed the MUC5AC levels in NA mice as well as in cultured HMGB1-induced human bronchial epithelial cells. Furthermore, the phospho- extracellular signal-regulated kinase (ERK) protein in NA was increased while the sRAGE intervention inhibited this elevation.

Conclusions: These results suggest that sRAGE may be a potential target for the treatment of mucus hypersecretion in NA.

Keywords

bronchial epithelial cells; mucus hypersecretion; neutrophilic asthma; p-ERK; sRAGE.

Figures
Products